Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis

• Status: Completed
• Trial end date: 2011-01-01

Summary

This study will investigate the safety and efficacy of olopatadine hydrochloride / ketorolac tromethamine fixed dose combination ophthalmic solution compared with olopatadine hydrochloride ophthalmic solution in patients with seasonal allergic conjunctivitis.

• Phase: Phase 3

Details

• Lead Sponsor: Allergan
• Treatments: Ketorolac; Ketorolac Tromethamine; Olopatadine Hydrochloride; Ophthalmic Solutions; Pharmaceutical Solutions